NCT04729101View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

June 12, 2021

Study Completion Date

June 26, 2021

Conditions
Healthy Participants
Interventions
DRUG

Vonoprazan

Oral tablet

DRUG

Lansoprazole

Oral capsule

Trial Locations (1)

85283

Celerion, 2420 W Baseline Rd,, Tempe

Sponsors
All Listed Sponsors
lead

Phathom Pharmaceuticals, Inc.

INDUSTRY